Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

147.00 +1.26 (+0.86%)
Streaming Delayed Price Updated: 12:59 PM EDT, Apr 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
91 92 Next >
Stock Market Sells Off; Taiwan Semi, ASML, Netflix, Tesla In Focus: Weekly Review
The Nasdaq and S&P 500 tumbled below their 50-day lines. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Brexit Impact On Drugs - Rising Shortages in UK Highlight Brexit Challenges
Discover the impact of Brexit on UK drug shortages. Insights from a recent Nuffield Trust study reveal a doubling in shortages since 2020. Learn about challenges in medicine supplies, regulatory... 
Via Benzinga
Topics Brexit
Exposures Brexit
Johnson & Johnson Children's Cough Syrup Contaminated In Some Batches - WHO Poised to Issue Global Alert
WHO alerts the global community about tainted children's cough syrup by Johnson & Johnson. Elevated toxin levels detected in Benylin syrup prompt recalls across Africa. Investigation is underway. 
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies
Following an investigation announced in November last year, the FDA said on Thursday that it would now require boxed warnings—the highest safety-rel 
Via Benzinga
Exposures Product Safety
Unpacking the Latest Options Trading Trends in Johnson & Johnson
Via Benzinga
Top Stock Reports For Nvidia, Alphabet And Johnson & Johnson
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Alphabet Inc. (GOOGL) and Johnson & Johnson (JNJ). 
Via Talk Markets
Recession-Proof Riches: 3 Stocks That Thrive in Any Economy
Discover recession-proof stocks that thrive amid economic uncertainty, offering stability and consistent growth. 
Via InvestorPlace
Want to Double Your Tax Refund in 2024? 7 Stocks to Buy Now.
Investors wondering which tax refund stocks to invest in should consider these names, each of which is a capital compounder. 
Via InvestorPlace
Johnson & Johnson Shares Hold Steady After Q1 Earnings, Analysts Optimistic About Future
Johnson & Johnson reports first-quarter earnings, with adjusted EPS up 12.4% and sales up 2.3%. Analysts optimistic about stock's future, highlighting potential growth from new drug approvals. JNJ aims... 
Via Benzinga
Johnson & Johnson Analysts Cut Their Forecasts After Q1 Results
Johnson & Johnson (NYSE: JNJ) reported better-than-expected first-quarter earnings on Tuesday. 
Via Benzinga
Invest Like a Hawk: 7 Stocks to Own If the Fed Stays Tough
Although monetary policy seemed to be moving in a dovish direction, a pivot may warrant a look at stocks for Fed hikes. 
Via InvestorPlace
Topics Economy
Exposures Interest Rates
Put $10,000 in These 3 Dividend Stocks by 2025
In market uncertainty, dividend stocks come to the rescue. Rebalance your portfolio with these three dividend stocks and enjoy steady income. 
Via InvestorPlace
Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Why Johnson & Johnson Stock Got Tossed by the Market Today
A mixed quarter and narrowed guidance didn't really please investors. 
Via The Motley Fool
Johnson & Johnson (JNJ) Q1 2024 Earnings Call Transcript
JNJ earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Stocks Grapple With Geopolitical Pressures, Gold Eyes $2,400, Bitcoin Falls Below $62,000: What's Driving Markets Tuesday?
Investors remain on edge as geopolitics continue to shape market trends, with Israel mulling a response to Iran while the U.S. and key allies explore further sanctions against Tehran. 
Via Benzinga
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff
On Tuesday, Johnson & Johnson (NYSE: JNJ) delivered a rather mixed first quarter report. Adjusted earnings surpassed estimates as sales in its medical devices business surged, while revenue was almost... 
Via Benzinga
JNJ Stock Earnings: Johnson & Johnson Beats EPS, Misses Revenue for Q1 2024
JNJ stock results show that Johnson & Johnson beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Johnson & Johnson Q1 Earnings Tops Wall Street Estimates On Strong Medical Devices Sales, Boosts Annual Outlook
Johnson & Johnson reports Q1 results: adjusted EPS $2.71 (up 12.4% Y/Y), sales $21.38B (up 2.3% Y/Y). Explore pharma giant's robust performance, including strong growth in Innovative Medicine and... 
Via Benzinga
Bellwether Health Giant J&J Beats Earnings Calls, But Shares Dip On Light Sales
The company reported light first-quarter sales, though earnings came in narrowly ahead. 
Via Investor's Business Daily
Earnings Turnaround For Johnson & Johnson With Q1 2024 Financial Results
Pharmaceutical and consumer staples titan Johnson & Johnson reported its Q1 2024 financial results this morning. 
Via Talk Markets
Buyback Bonanza: The Top 7 ETFs to Profit From Corporate Cash Splurges
Profit from corporate cash splurges with these top ETFs targeting buyback strategies. Unlock potential gains in a volatile market. 
Via InvestorPlace
Topics ETFs
Wall Street Braces For Mixed Open As Middle-East Tensions Offset Earnings Optimism: Analyst Points To Silver Lining In Rally Break
Earnings optimism may partly offset worries concerning rising bond yields and the volatile geopolitical situation in the Middle East, with the index futures trading mixed early 
Via Benzinga
Topics Bonds
Exposures Debt Markets
Earnings Scheduled For April 16, 2024
Companies Reporting Before The Bell • Traws Pharma (NASDAQ:TRAW) is expected to report earnings for its fourth quarter. 
Via Benzinga
Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead
Healthcare stocks disappointed again last week with the XLV down over 3% and up only 1.65 % YTD, in a continued downtrend since March 28. 
Via Talk Markets
Johnson & Johnson Likely To Report Higher Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Johnson & Johnson (NYSE: JNJ) is set to release earnings results for its first quarter before the opening bell on April 16, 2024. 
Via Benzinga
Bank of America, Morgan Stanley And 3 Stocks To Watch Heading Into Tuesday
With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Fear & Greed Index Moves To 'Fear' Zone; S&P 500 Down Over 1%
The CNN Money Fear and Greed index showed a decline in the overall market sentiment, with the index moving to the "Fear" zone on Monday. U.S. stocks closed lower on Friday amid concerns over the... 
Via Benzinga
Topics Stocks
Exposures US Equities
J&J Braces For Q1 Earnings With Bearish Charts And Patent Cliffs In Play
Johnson & Johnson's Q1 earnings report on April 16 is expected to show $2.64 EPS and $21.4 billion in revenues. Technical analysis shows a bearish trend but analysts have a neutral rating with a... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Medical Device Manufacture Integer To Gain From Expanding Pulsed Field Ablation Market, Earns Upgrade From BofA
BofA Securities' upgrades Integer, highlighting the growth potential of pulsed field ablation (PFA) in atrial fibrillation treatment. With projections of PFA sales skyrocketing from $100-200 million in... 
Via Benzinga
Topics Supply Chain
Exposures Supply Chain
< Previous 1 2 3 4 5 6 7 8 9
...
91 92 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.